Medical Condition News

RSS

Benefits of moderate alcohol drinking on stroke risk counteracted by cigarette smoking

New research finds any beneficial effect of drinking moderate amounts of alcohol on stroke may be counteracted by cigarette smoking, according to research that will be presented as part of the late-breaking science program at the American Academy of Neurology's 62nd Annual Meeting in Toronto, April 10 - 17, 2010.

13 Apr 2010

AACR Annual Meeting 2010: Æterna Zentaris to present data on Erk/PI3K inhibitor compounds

Æterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it will make an oral presentation, as well as a poster presentation on Erk/PI3K inhibitor compounds, Tuesday, April 20, at the American Association for Cancer Research (AACR) Annual Meeting, to be held April 17-21, 2010 at the Walter E. Washington Convention Center in Washington, D.C.

13 Apr 2010

Clinical trial data on AMPYRA Extended Release Tablets to be presented at AAN Annual meeting

Acorda Therapeutics, Inc. today announced that four new analyses of clinical trial data on AMPYRA™ (dalfampridine) Extended Release Tablets 10 mg are being presented at the 62nd American Academy of Neurology Annual meeting.

13 Apr 2010

Woodford Reserve $1,000 Mint Julep Cup: The Barnstable Brown Kentucky Diabetes & Obesity Center beneficiary

Woodford Reserve bourbon will celebrate the glamour and glitz of the Kentucky Derby® with the Ultimate Kentucky Derby Luxury: the world's most exclusive mint julep cup. The Woodford Reserve $1,000 Mint Julep Cup Experience will feature a collection of 73 silver cups designed by Tiffany & Co. exclusively for Woodford Reserve. Proceeds from the cups will benefit The Barnstable Brown Kentucky Diabetes & Obesity Center.

13 Apr 2010

Inflammasome components help protect against colitis

Particular components of inflammasomes-protein complexes needed for generating immune responses to pathogens and cellular damage-lessen the severity of colitis and colitis-associated colon cancer in mice, according to a study published online this week in the Journal of Experimental Medicine.

13 Apr 2010

Implicit association between death/ suicide and self may indicate suicide risk

Following the suicide of a relative or close friend, surviving family members and friends are left with a number of painful questions: "What made them do it?," "Why didn't they get help?" The most troublesome question is often, "Is there anything I could have done to prevent this?" People who are contemplating suicide tend to conceal their behavior, or deny they are having suicidal thoughts, so it can be difficult to identify warning signs.

13 Apr 2010

Immunomedics' progress in cancer therapy product candidates to be presented at AACR 2010

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that eight presentations reporting on the Company's progress in diverse cancer therapy product candidates will be given at the 101st Annual Meeting of the American Association for Cancer Research, April 17 – 21, 2010, in Washington, DC.

13 Apr 2010

VBL Therapeutics announces upcoming presentations at premier dermatology and cancer research meetings

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immuno-inflammatory diseases and cancer, today announced the upcoming presentations of clinical data from the company's two lead programs, VB-201 and VB-111, at premier dermatology and cancer research medical meetings this spring.

13 Apr 2010

Over 17,000 scientists convene at AACR 101st Annual Meeting 2010

Scientific breakthroughs in molecular targeting, translational cancer research and cancer prevention will take center stage when more than 17,000 scientists from around the world gather at the Walter E. Washington Convention Center, April 17-21, for the AACR 101st Annual Meeting 2010.

13 Apr 2010

Delcath's Phase III PHP-mel trial data accepted for presentation at ASCO's 2010 Annual Meeting

Delcath Systems, Inc., a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced today that the American Society of Clinical Oncology (ASCO) has accepted an abstract for oral presentation of Delcath's Phase III Trial Data comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to the best alternative care for patients with hepatic metastases from ocular or cutaneous melanoma for ASCO's 2010 Annual Meeting, to be held June 4-8, 2010 at McCormick Place in Chicago.

13 Apr 2010

New driving guideline for people with Alzheimer's disease

The American Academy of Neurology has issued a new guideline to help determine when people with Alzheimer's disease or another type of dementia should stop driving. The guideline is published in the April 12, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology, and was presented at the American Academy of Neurology's Annual Meeting in Toronto.

13 Apr 2010

High level of microRNAs found in patients with high-risk multiple myeloma

Multiple myeloma researchers at the University of Arkansas for Medical Sciences (UAMS) recently discovered that widespread activity of a specific class of genes can identify aggressive, or high-risk, cases of the disease.

13 Apr 2010

Investment report on Rexahn Pharmaceuticals

StockPreacher.com announces an investment report featuring Rexahn Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

13 Apr 2010

'Mindfulness' for reducing aggressive behaviour in people with developmental disabilities

A very ancient and effective practice - mindfulness - is being given a new and surprising application. For the first time ever, mindfulness is being used to reduce the likelihood of aggressive behaviour in people with developmental disabilities as well as mental health problems.

13 Apr 2010

Circadian cell division gets disrupted due to artificial light at night

Just one "pulse" of artificial light at night disrupts circadian cell division, reveals a new study carried out by Dr. Rachel Ben-Shlomo of the University of Haifa-Oranim Department of Environmental and Evolutionary Biology along with Prof. Charalambos P. Kyriacou of the University of Leicester. "Damage to cell division is characteristic of cancer, and it is therefore important to understand the causes of this damage," notes Dr. Ben-Shlomo. The study has been published in the journal Cancer Genetics and Cytogenetics.

13 Apr 2010

Dalhousie University interdisciplinary cooperation leads to innovation of Femoral Fracture Reduction device

It's late at night when most of the city is sleeping and the hospital is eerily quiet. But in the operating room, a tired but undeterred surgeon is struggling through a femoral fracture reduction on a young patient. The surgery, which is usually a meticulous and straightforward procedure, is not going smoothly. After wrestling with the fracture, he has no choice but to take a more invasive approach. He cuts open the femur and reduces the fracture—if not, displaced fat and marrow could cause a fat embolism in the lungs.

13 Apr 2010

Touching story of young man fighting Alzheimer's disease

In her new unwavering memoir, Jim's Journey: The Story of a Young Man with Early On-set Alzheimer's (published by Trafford Publishing), debut author Gretchen L Dausey reveals the touching story of her husband's battle against Alzheimer's disease and her unwavering support despite the inevitable degeneration of his mind and body.

13 Apr 2010

BioTrends Research Group, NKF publish Special Report on patients with CKD

BioTrends Research Group, Inc. and the National Kidney Foundation announce the publication of a Special Report: Patient Perspectives in Dialysis and Chronic Kidney Disease. This important new syndicated study provides insights into patients with kidney disease, from the patients themselves. Over 1,100 patients in the U.S. -- both those on dialysis and those with mid-late stage chronic kidney disease -- completed a survey about living with CKD.

13 Apr 2010

'Forgotten' cells in brain cancer

Glioblastoma is a guileful enemy. While most of the brain tumor can often be removed surgically, in virtually every case the tumor reappears. One reason for this is that sporadic, infiltrative tumor cells will remain in the brain even after most careful surgery. Researchers at the University of Bonn have now subjected these 'forgotten' cells to closer scrutiny for the first time.

13 Apr 2010

American Lung Association's report examines lung cancer among African Americans

The American Lung Association today released its report, Too Many Cases, Too Many Deaths: Lung Cancer in African Americans, a compilation of research examining lung cancer among African Americans and the need to eliminate this and other health disparities.

13 Apr 2010

Medical Condition News

Benefits of moderate alcohol drinking on stroke risk counteracted by cigarette smoking

AACR Annual Meeting 2010: Æterna Zentaris to present data on Erk/PI3K inhibitor compounds

Clinical trial data on AMPYRA Extended Release Tablets to be presented at AAN Annual meeting

Woodford Reserve $1,000 Mint Julep Cup: The Barnstable Brown Kentucky Diabetes & Obesity Center beneficiary

Inflammasome components help protect against colitis

Implicit association between death/ suicide and self may indicate suicide risk

Immunomedics' progress in cancer therapy product candidates to be presented at AACR 2010

VBL Therapeutics announces upcoming presentations at premier dermatology and cancer research meetings

Over 17,000 scientists convene at AACR 101st Annual Meeting 2010

Delcath's Phase III PHP-mel trial data accepted for presentation at ASCO's 2010 Annual Meeting

New driving guideline for people with Alzheimer's disease

High level of microRNAs found in patients with high-risk multiple myeloma

Investment report on Rexahn Pharmaceuticals

'Mindfulness' for reducing aggressive behaviour in people with developmental disabilities

Circadian cell division gets disrupted due to artificial light at night

Dalhousie University interdisciplinary cooperation leads to innovation of Femoral Fracture Reduction device

Touching story of young man fighting Alzheimer's disease

BioTrends Research Group, NKF publish Special Report on patients with CKD

'Forgotten' cells in brain cancer

American Lung Association's report examines lung cancer among African Americans

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News